Cargando…
Establishment and Investigation of a Multiple Gene Expression Signature to Predict Long-Term Survival in Pancreatic Cancer
Pancreatic cancer remains a lethal type of cancer with poor prognosis. Molecular classification enables in-depth, precise prognostic assessment. This study is aimed at identifying a robust and simple mRNA signature to predict the overall survival (OS) of pancreatic cancer (PC) patients. Differential...
Autores principales: | Zhang, Zhiqiang, Gu, Jiangning, Yin, Menghong, Wang, Di, Ma, Chi, Du, Jian, Lin, Zhikun, Hu, Siling, Wang, Xuelong, Li, Ying, Tan, Guang, Luo, Haifeng, Wei, Gang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7516738/ https://www.ncbi.nlm.nih.gov/pubmed/33015155 http://dx.doi.org/10.1155/2020/1570862 |
Ejemplares similares
-
Safety and efficacy of S1 monotherapy or combined with nab-paclitaxel in advanced elderly pancreatic cancer patients: A meta-analysis
por: Chen, Yunlong, et al.
Publicado: (2021) -
Neoadjuvant Therapy for Pancreatic Ductal Adenocarcinoma: Where Do We Go?
por: Wang, Chenqi, et al.
Publicado: (2022) -
ORM 1 as a biomarker of increased vascular invasion and decreased sorafenib sensitivity in hepatocellular carcinoma
por: Gu, Jiangning, et al.
Publicado: (2022) -
Establishing and validating an ADCP-related prognostic signature in pancreatic ductal adenocarcinoma
por: Zhang, Deyu, et al.
Publicado: (2022) -
Importance of gene expression signatures in pancreatic cancer prognosis and the establishment of a prediction model
por: Yan, Xiaokai, et al.
Publicado: (2018)